Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

FDA Warns Consumers to Stop Using Soladek Vitamin Solution

March 28, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., March 28, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is warning consumers to stop using Soladek, a vitamin-solution product marketed by Indo Pharma, S.A., of the Dominican Republic, because the product may contain dangerously high levels of...

Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American Colle...

March 28, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

BASKING RIDGE, N.J., March 28, 2011 /- Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that Thomas J. Povsic, MD, PhD, Assistant Professor of Medicine at Duke University, will present results of...

AmeriCares and AstraZeneca Work Together Delivering Critical Medicines to Help People Living with Chronic Diseases in the U.S.

March 28, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

STAMFORD, Conn., March 28, 2011 /PRNewswire-USNewswire/ -- AmeriCares and AstraZeneca have teamed to deliver critical medicines to help people living with chronic diseases throughout the United States. AstraZeneca has donated $5 million in cardiovascular and gastrointestinal medications...

Advertisement

Chimerix Appoints Timothy W. Trost Senior Vice President, Chief Financial Officer

March 28, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

DURHAM, N.C., March 28, 2011 /- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, announced today that Timothy W. Trost has joined the company as Senior Vice President, Chief Financial Officer. Mr. Trost brings to Chimerix more than 30 years of...

New Interim Data About Combination Oral Contraceptives

March 25, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

WAYNE, N.J., March 25, 2011 /- Bayer HealthCare Pharmaceuticals Inc. today announced that interim results from a large, prospective, observational cohort safety study offer insights into the increased risk of venous thromboembolism (VTE), or blood clots, which is a well-established risk...

CoreLab Partners Collaborates at Worldwide Industry Conferences

March 25, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., March 25, 2011 /- CoreLab Partners, Inc , the global entity resulting from the merger between RadPharm, Inc and Medifacts International, is set to attend and actively participate in several upcoming industry events around the world over the next two weeks. "The legacy of...

Med Ad News Magazine Announces Nominees for the 22nd Annual Manny Awards as Well as Advertising Person of the Year

March 25, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

NEWTOWN, Pa., March 25, 2011 /- Today, Med Ad News announces the nominees for the 22nd Annual Manny Awards and the Advertising Person of the Year. The awards ceremony will be held on Thursday, April 28, 2011, at the Sheraton New York Hotel and Towers in New York, N.Y. The Manny Awards is...

Heyltex Corporation Working With United States and Japan to Add Production of Radiological Antidotes

March 25, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

KATY, Texas, March 25, 2011 /PRNewswire-USNewswire/ -- Heyltex Corporation is the exclusive U.S. distributor of Radiogardase® (Prussian Blue insoluble capsules), the only FDA-approved drug to treat people who have been internally contaminated with radioactive cesium (Cs-137), which...

Advertisement

Medco Foundation Donates $100,000 to Red Cross for Japanese Earthquake and Pacific Tsunami Relief

March 24, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J., March 24, 2011 /- The Medco Foundation, a charitable organization established by Medco Health Solutions Inc., (NYSE: MHS ), has donated $100,000 to the U.S. Red Cross to assist in the global humanitarian relief effort for victims of the devastating earthquake in...

Omthera Pharmaceuticals, Inc. to Present at the BIO Windhover/Pharmaceutical Strategic Outlook 2011 Conference

March 24, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

BEDMINSTER, N.J., March 24, 2011 /- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that Jerry Wisler, President and Chief Executive Officer, will present at the BIO Windhover/Pharmaceutical Strategic Outlook 2011 Conference at...

Christiana Care Health System Leads National Colorectal Cancer Clinical Trial

March 24, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

WILMINGTON, Del., March 24, 2011 /PRNewswire-USNewswire/ -- Christiana Care Health System's Helen F. Graham Cancer Center is leading a national clinical trial to determine if Crestor® (Rosuvastatin), a cholesterol-lowering drug, can prevent new colon tumors from forming after colon...

ICAP Ocean Tomo Announces Auction of Patch Based Drug Delivery and Monitoring Techniques from Entrega Laboratories, LLC

March 23, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

CHICAGO, March 23, 2011 /- Available at ICAP Ocean Tomo's Spring 2011 Live IP Auction, this patent portfolio discloses methods and techniques related to patch-based drug delivery and monitoring. (Logo:   http://photos.prnewswire.com/prnh/20100614/CG20517LOGO ) Background...

Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich's Genousâ„¢ Stent in Diabetic Patients

March 23, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

HONG KONG, March 23, 2011 /- OrbusNeich today announced that 12-month outcomes data from a subset analysis of the global e-HEALING registry were published online ahead of print in the Journal of Interventional Cardiology and demonstrated the effectiveness and safety of the company's...

Advertisement

Boston Scientific to Webcast Analyst Event

March 22, 2011 1:34 pm | by Boston Scientific | News | Comments

NATICK, Mass., March 22, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it will hold an analyst event on April 4, 2011 at the 60th Annual Scientific Session of the American College of Card

Terso Solutions Launches New RFID-Enabled Refrigerator for Hospital and Laboratory Inventory Management

March 22, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., March 22, 2011 /- Terso Solutions, Inc. has expanded its line of RFID-enabled enclosures with the addition of a new refrigerator that is well-suited for hospital and laboratory inventory management . Leveraging the power of RFID, the new refrigerator makes better use of...

Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit

March 21, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, March 21, 2011 /- Attorneys from Dallas' Heygood, Orr & Pearson are announcing a Los Angeles Superior Court ruling that will require executives from Watson Pharmaceuticals Inc. (NYSE: WPI ) and its subsidiary companies to testify under oath and produce key documents as...

Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases

March 21, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

HARRISBURG, Pa., March 21, 2011 /- Beginning April 1, Highmark Blue Cross Blue Shield (Highmark) will force a number of their insured patients with primary immunodeficiency diseases and other rare disorders to switch their prescription to a single brand of immunoglobulin (IgG - a blood...

OrbusNeich Files Lawsuit Against Dr. Pavel Cervinka for Defamation

March 21, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

HONG KONG, March 21, 2011 /- OrbusNeich today announced that it has filed a lawsuit in the Netherlands against Dr. Pavel Cervinka and Masaryk Hospital in Usti nad Labem, Czech Republic, where Dr. Cervinka is head of the hospital's Cardiology Department. The suit relates to a clinical...

A Smoking Gun for Emphysema

March 20, 2011 8:32 pm | by Massachusetts Institute of Technology | News | Comments

A new blood test may detect signs of the disease before symptoms appear.

New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies

March 19, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

KING OF PRUSSIA, Pa., March 19, 2011 /- CSL Behring today announced the development of an innovative pharmacokinetic (PK) model that allows the absorption, distribution, metabolism, and elimination of subcutaneous (SC) immunoglobulin G (IgG) following administration to be simulated with a...

Covidien Announces FDA Advisory Committee Unanimously Recommends Approval for Pipeline(TM) Embolization Device

March 18, 2011 7:35 pm | by Covidien | News | Comments

MANSFIELD, Mass., Mar 18, 2011 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel voted to recommend approval for Pipeline(TM) Embolization Device,...

BridgePoint Medical Names Industry Veteran as Chief Executive Officer

March 18, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, March 18, 2011 /- BridgePoint Medical, Inc., a Minnesota based medical device company, has announced that Denis Harrington has joined the company as President and Chief Executive Officer.  A seasoned medical device executive with nearly two decades of experience in the...

Midland Family Undergoes Bariatric Surgery at Hurley Medical Center--Loses 445 Pounds & Countingâ??Tells their Life-Saving Story to Media on March 18, 2011

March 18, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

FLINT, Mich., March 18, 2011 /PRNewswire-USNewswire/ -- The Aeschliman family of Midland, Michigan have a new lease on life. Nancy Aeschliman Grau and her three children—Katie, Chris, and Mike ALL underwent Roux-en-Y bariatric surgery at Hurley Medical Center—the first...

Giant Eagle® Receives American Diabetes Association Chairman's Citation Award

March 17, 2011 9:32 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, March 17, 2011 /- Giant Eagle®, the region's leading food and fuel retailer, has received the American Diabetes Association's (ADA) prestigious Chairman's Citation Award. Giant Eagle is the second ever recipient of the Award, which recognizes the outstanding...

Amarin Reports Year-End and Q4 2010 Results

March 17, 2011 5:31 am | by Bio-Medicine.Org | News | Comments

DUBLIN and MYSTIC, Conn., March 16, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ), a clinical-stage biopharmaceutical company focused on cardiovascular disease, today reported financial results for the fiscal year and fourth quarter ended December 31, 2010. The Company also provided an...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading